My computer issues have been sorted, so here’s the full scoop behind my meeting with the medical oncologist (MO) on Tuesday. The meeting started with a nurse practitioner (NP) which threw my for a bit of a loop and initial disappointment. Because this was my initial contact with the oncology team, we spent a bit ..read more

This will be a Reader’s Digest version of a future longer post. My computer died Sunday night and I’m not keen on trying to type out the full report on my phone’s itty-bitty keyboard. The bottom line for now is to watch my PSA for the next three to six months, perhaps with another PSMA ..read more

My first meeting with a medical oncologist is a week from Tuesday, on 19 March, so I’ve been putting together a series of questions to ask. I’d like to leave the meeting with an understanding of whether there’s value in delaying the start of hormone therapy so my PSA can get high enough for a ..read more

I came across this fact sheet on hormone therapy from the National Cancer Institute that does a great job of explaining it all to the uninitiated. https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet ..read more

A moderator on the HealthUnlocked website shared a link to the new 2024 American Urological Association guidelines for salvage therapy for recurrent prostate cancer: https://www.auanet.org/guidelines-and-quality/guidelines/salvage-therapy-for-prostate-cancer These are the generally agreed-upon guidelines that practitioners should follow when a patient has recurrent prostate cancer after initial treatment ..read more

Here’s another informative video about hormone therapy from the Prostate Cancer Research Institute. It answered some of the questions that I had from the previous video. Specifically ..read more

Another timely video from the Prostate Cancer Research Institute talking about the recent EMBARK study that examines combination ADT + enzalutamide therapy versus Lupron alone or enzalutamide alone. (The study was funded by Pfizer and Astellas Pharma, the manufacturers of enzalutamide.) There were 1,068 patients divided into three groups that were followed for five years ..read more

Here’s another timely (for me) and educational video from Dr. Scholz and the Prostate Cancer Research Institute. I have an appointment with the medical oncologist on 19 March, and this has given me a good foundation for the discussion ..read more

Today’s meeting with the urologist went about as I expected it would. In a nutshell, we agreed to punt for another three months and see where we’re at with a new PSA test at that time. We talked about the clean PSMA PET scan results and the fact that we remain in this inconclusive gray ..read more

No evidence of recurrent prostate cancer or metastatic disease. I know I should be excited but, at the same time, I don’t think I’ve been so frustrated by “good” news. Thanks to the steady increase in my PSA, we know something is happening somewhere, and I was really hoping this scan would end the game ..read more